105 assets in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Selinexor

Dexasone

Axicabtagene Ciloleucel

Cyclophosphamide

Etoposide

Isocyclophosphamide

Adriamycin

Carboplatin

Cytarabine

Prednisone

Fludarabine

Hmpl-760

Ibrutinib

Jcar-017 Cd19-Specific Chimeric Antigen Receptor

Lenalidomide

Polatuzumab Vedotin

Vincristine Sulfate

Camustine

Nivestim

Pembrolizumab

Rituximab

Melphalan

Oxaliplatin

Nivolumab

Bebt-908 For

Cis-Diamminedichloroplatinum Ii

Golcadomide

Ifupinostat Hydrochloride For

Kite-753

Purinostat Mesylate For

Rondecabtagene Autoleucel

Tucidinostat

Venetoclax

Atezolizumab

Bendamustine

Obinutuzumab

Zanubrutinib

Dpx-Survivac

Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)

Vorinostat

Zilovertamab Vedotin

Busulfanum

Decitabine

Epcoritamab

Romidepsin

Tacrolimus

Tafasitamab

Loncastuximab Tesirine

Catequentinib

F007